MedTrace Logo

Partial Breast Irradiation in a Low-risk Population Screened With MRI

NCT01255553 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-03-04

No results posted yet for this study

Summary

This is a pilot study to determine if partial breast irradiation (PBI) limited to the region of the tumor bed following lumpectomy in patients screened with MRI provides historically similar rates of local failure, limited acute skin toxicity, late complications and cosmetic outcome when compared to patients treated with standard 3D-CRT to the whole breast.

Conditions

Interventions

RADIATION

Partial Breast Irradiation

Partial breast irradiation will be administered using a 3D conformal external beam RT technique. Two fractions of 38.5 Gy separated by at least 6 hours will be given on 5 treatment days over a period of 5 to 10 days.

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Steven Chmura, MD · University of Chicago

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01255553 on ClinicalTrials.gov